Dr Purnima Sundaresan

Clinical Lecturer
Medicine, Central Clinical School


Map

Awards and honours

National Health & Medical Research Council, Medical Postgraduate Research Scholarship - project titled "Exploring barriers to radiotherapy utilization"

Research Scholarship

Selected grants

2013

  • Evaluating the Utility of a Patient Decision Aid for Prospective Participants in the TROG RAVES Prostate Cancer Trial (TROG 08.03); Sundaresan P, Bell M, Kneebone A, Turner S, Butow P; Prostate Cancer Foundation of Australia/Young Investigator Grants.

2012

  • A randomised controlled trial testing a Decision Aid to promote informed consent and recruitment to the TROG 08.03 (RAVES) trial of post-prostatectomy radiotherapy; Butow P, Sundaresan P, Sundaresan P; Royal Australian and New Zealand College of Radiologists/Ferring Pharmaceuticals Grant.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Turner, S., Sundaresan, P., Mann, K., Pryor, D., Gebski, V., Shaw, T. (2016). Engaging Future Clinical Oncology Researchers: An Initiative to Integrate Teaching of Biostatistics and Research Methodology into Specialty Training. Clinical Oncology, 28(5), 306-316. [More Information]
  • Tesson, S., Sundaresan, P., Ager, B., Butow, P., Kneebone, A., Costa, D., Woo, H., Pearse, M., Juraskova, I., Turner, S. (2016). Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03). Radiotherapy and Oncology, 119(1), 84-90. [More Information]
  • Kader, I., Leavers, B., Shashinder, S., Wylie, B., Chi, K., Sundaresan, P. (2016). Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: A diagnostic and management dilemma. Journal of Laryngology and Otology, 130(S4), S45-S49. [More Information]
  • Sundaresan, P., Stockler, M., Milross, C. (2016). What is access to radiation therapy? A conceptual framework and review of influencing factors. Australian Health Review, 40(1), 11-18. [More Information]
  • Sundaresan, P., King, M., Stockler, M., Costa, D., Milross, C. (2015). Barriers to radiotherapy utilisation in New South Wales Australia: Health professionals' perceptions of impacting factors. Journal of Medical Imaging and Radiation Oncology, 59(4), 535-541. [More Information]
  • Lam, J., Cook, T., Foster, S., Poon, R., Milross, C., Sundaresan, P. (2015). Examining Determinants of Radiotherapy Access: Do Cost and Radiotherapy Inconvenience Affect Uptake of Breast-conserving Treatment for Early Breast Cancer? Clinical Oncology, 27(8), 465-471. [More Information]
  • Sundaresan, P., Sullivan, L., Pendlebury, S., Kirby, A., Rodger, A., Joseph, D., Campbell, I., Dhillon, H., Stockler, M. (2015). Patients' Perceptions of Health-related Quality of Life During and After Adjuvant Radiotherapy for T1N0M0 Breast Cancer. Clinical Oncology, 27(1), 9-15. [More Information]
  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Fraser-Browne, C., Woo, H. (2014). Do Screening Trial Recruitment Logs Accurately Reflect the Eligibility Criteria of a Given Clinical Trial? Early Lessons from the RAVES 0803 Trial. Clinical Oncology, 26(6), 348-352. [More Information]
  • Sundaresan, P., Milross, C., Smith, A., Evans, A., Stockler, M., King, M. (2014). Factors influencing the use of RT in NSW: A qualitative study exploring consumer and health professional perspectives. Journal of Medical Imaging and Radiation Oncology, 58(5), 625-632. [More Information]
  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012). Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology, 24(9), e131-e136. [More Information]
  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Butow, P. (2011). Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03). Radiotherapy and Oncology, 101(3), 521-524. [More Information]
  • Sundaresan, P., Jayamohan, J. (2008). Stereotactic radiotherapy for the treatment of neurosarcoidosis involving the pituitary gland and hypothalamus. Journal of Medical Imaging and Radiation Oncology, 52(6), 622-626. [More Information]

2016

  • Turner, S., Sundaresan, P., Mann, K., Pryor, D., Gebski, V., Shaw, T. (2016). Engaging Future Clinical Oncology Researchers: An Initiative to Integrate Teaching of Biostatistics and Research Methodology into Specialty Training. Clinical Oncology, 28(5), 306-316. [More Information]
  • Tesson, S., Sundaresan, P., Ager, B., Butow, P., Kneebone, A., Costa, D., Woo, H., Pearse, M., Juraskova, I., Turner, S. (2016). Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03). Radiotherapy and Oncology, 119(1), 84-90. [More Information]
  • Kader, I., Leavers, B., Shashinder, S., Wylie, B., Chi, K., Sundaresan, P. (2016). Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: A diagnostic and management dilemma. Journal of Laryngology and Otology, 130(S4), S45-S49. [More Information]
  • Sundaresan, P., Stockler, M., Milross, C. (2016). What is access to radiation therapy? A conceptual framework and review of influencing factors. Australian Health Review, 40(1), 11-18. [More Information]

2015

  • Sundaresan, P., King, M., Stockler, M., Costa, D., Milross, C. (2015). Barriers to radiotherapy utilisation in New South Wales Australia: Health professionals' perceptions of impacting factors. Journal of Medical Imaging and Radiation Oncology, 59(4), 535-541. [More Information]
  • Lam, J., Cook, T., Foster, S., Poon, R., Milross, C., Sundaresan, P. (2015). Examining Determinants of Radiotherapy Access: Do Cost and Radiotherapy Inconvenience Affect Uptake of Breast-conserving Treatment for Early Breast Cancer? Clinical Oncology, 27(8), 465-471. [More Information]
  • Sundaresan, P., Sullivan, L., Pendlebury, S., Kirby, A., Rodger, A., Joseph, D., Campbell, I., Dhillon, H., Stockler, M. (2015). Patients' Perceptions of Health-related Quality of Life During and After Adjuvant Radiotherapy for T1N0M0 Breast Cancer. Clinical Oncology, 27(1), 9-15. [More Information]

2014

  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Fraser-Browne, C., Woo, H. (2014). Do Screening Trial Recruitment Logs Accurately Reflect the Eligibility Criteria of a Given Clinical Trial? Early Lessons from the RAVES 0803 Trial. Clinical Oncology, 26(6), 348-352. [More Information]
  • Sundaresan, P., Milross, C., Smith, A., Evans, A., Stockler, M., King, M. (2014). Factors influencing the use of RT in NSW: A qualitative study exploring consumer and health professional perspectives. Journal of Medical Imaging and Radiation Oncology, 58(5), 625-632. [More Information]

2012

  • Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M., Thompson, J. (2012). Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma. Clinical Oncology, 24(9), e131-e136. [More Information]

2011

  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Butow, P. (2011). Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03). Radiotherapy and Oncology, 101(3), 521-524. [More Information]

2008

  • Sundaresan, P., Jayamohan, J. (2008). Stereotactic radiotherapy for the treatment of neurosarcoidosis involving the pituitary gland and hypothalamus. Journal of Medical Imaging and Radiation Oncology, 52(6), 622-626. [More Information]

To update your profile click here. For support on your academic profile contact .